Short ZIOP. Retail Gets Slaughtered
March 26, 2013
  Shares of Ziopharm Oncology (ZIOP) plunged by 64% to $1.82 on Tuesday when it released news that its only late stage drug candidate failed to meet its primary endpoint....
Short ZIOP. Undisclosed FDA warning letter
October 21, 2012
A close investigation of Ziopharm (ZIOP) reveals an undisclosed FDA warning letter and instability with Palifosfamide